我国血管腔内外科技术发展历程.docVIP

. .. 我国血管腔内外科技术发展的历程 【摘要】 我国腔内血管外科从无到有，从粗到精，从盲目到定向，从少到多，而今从多到即将来临的如雨后春笋般的前景，首先有赖于科学这个第一生产力的蓬勃发展，也有赖于医务界诸多同仁孜孜不倦的勤恳耕耘，她经历了一个艰苦创业和发展的历程。本文所述的主要为大血管外科:腔静脉和肾动脉平面以上主动脉疾病的腔内治疗，但仍起自中等管径动脉的研究和实践开始。迄今，仅笔者等就已成功完成了137例以上的以主动脉夹层为主的大动脉病变的腔内治疗，在全国范围内则估计已过千例，似远多于肾下腹主动脉瘤的血管腔内治疗，这一点同西方国家似乎完全不同。可以肯定的是，应用血管腔内技术或手术联合腔内法治疗大血管病变（肾动脉平面以上）较治疗身体其他部位血管病变具有更大的优越性。总之，无论是以血管腔内微创法或手术与腔内联合法治疗大血管病变的研究和治疗均尚方兴未艾，其前景可观。 　　【关键词】 血管腔内移植物；主动脉夹层；动脉瘤；下腔静脉；布加综合征　　【Abstract】 The endovascular surgery in China has been developing from none to a few,a few to many, and it is expecting to growth even rapidly as “spring bamboo after a timely rain” in which “science is the first motive force” and a consistent diligence and endeavor putting into it from vascular scientists and practitioners has been playing a distinctively important role. It has experienced a hard initiation and developing process. Describing here is mainly the development of endolumianl vascular surgery for major vein and artery, i.e., the vena cava and the aorta, however it was still from research and practice of the medium-sized vessels. Until now, we have treated more than 137 cases.The total number of patients with aortic dissection treated by endografting should be more than 1000. The endoluminal treatment, including the hybrid or semi-interventional method for treating aortic dissection is very likely to have a particularly specially better future future in comparison to the treatment for those with the infra-renal abdominal aortic aneurysm AAA in which requires, unlikely the surgical procedures for handling aortic dissections with long segmental involvement of the aorta, less surgical demanding. It is predicted that the distinctively difference we have had now between China and the Western World in term of the incidence of AAA and aortic dissections and their related treatment would be gradually disappeared in the future. The endoluminal treatment for treating greater vessel disorders has a fruitful future. 　　【Key words】 endograft;aorti